PANK4 and glioblastoma: More specifically, we showed that combined abrogation of PANK4 and TMZ treatment leads to attenuation of cell proliferation and clonogenicity, increased cell death in TMZ‐resistant GBM models, as well as decreased tumor growth in vivo.